文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

无创通气治疗肺炎所致早期轻度急性呼吸窘迫综合征的多中心随机对照试验

A multicenter RCT of noninvasive ventilation in pneumonia-induced early mild acute respiratory distress syndrome.
PubMed 文献 · Crit Care · 2019-09-04
一句话结论在肺炎所致早期轻度ARDS(PaO2/FIO2 200–300)患者中,与文丘里面罩吸氧相比,早期无创通气虽改善氧合但未减少插管需求。

这项前瞻性多中心随机对照试验纳入200例肺炎所致早期轻度ARDS(PaO2/FIO2 200–300)患者,随机分为无创通气组(n=102)和文丘里面罩吸氧对照组(n=98),来自21个中心。主要终点为符合插管标准的患者数。结果显示无创通气组与对照组插管比例无显著差异(11/102 vs 9/98,10.8% vs 9.2%,p=0.706),ICU死亡率亦相似(7/102 vs 7/98,4.9% vs 3.1%,p=0.721)。无创通气组在随机化后2小时PaO2/FIO2显著高于对照组并维持稳定至72小时。多因素分析显示48小时分钟通气量大于11 L/min是无创通气失败的独立危险因素(OR 1.176,95%CI 1.005–1.379,p=0.043)。

要点

  • 肺炎所致早期轻度ARDS(PaO2/FIO2 200–300)患者中,早期无创通气未减少插管需求(11/102 vs 9/98,10.8% vs 9.2%,p=0.706)。
  • 无创通气组ICU死亡率与对照组相似(7/102 vs 7/98,4.9% vs 3.1%,p=0.721)。
  • 无创通气组随机化后2小时PaO2/FIO2显著高于对照组,并稳定维持至72小时。
  • 48小时分钟通气量大于11 L/min是无创通气失败的独立危险因素(OR 1.176,95%CI 1.005–1.379,p=0.043)。

适用人群与场景

  • 肺炎所致早期轻度急性呼吸窘迫综合征患者,PaO2/FIO2介于200至300之间。

诊断标准与关键阈值

  • 早期轻度ARDS定义:PaO2/FIO2介于200至300。
  • 主要终点为符合插管标准的患者数。

处置流程与药物剂量

  • 无创通气组接受无创通气治疗。
  • 对照组通过文丘里面罩接受传统氧疗。

研究设计与关键结果

  • 前瞻性多中心随机对照试验,纳入200例患者,来自21个中心,随机分为无创通气组(n=102)和对照组(n=98)。
  • 主要终点:无创通气组符合插管标准的比例为10.8%(11/102),对照组为9.2%(9/98),p=0.706,无显著差异。
  • ICU死亡率:无创通气组4.9%(7/102),对照组3.1%(7/98),p=0.721,无显著差异。
  • 无创通气组随机化后2小时PaO2/FIO2显著高于对照组,并在前72小时保持稳定。
  • 多因素分析:48小时分钟通气量大于11 L/min是无创通气失败的独立危险因素(OR 1.176,95%CI 1.005–1.379,p=0.043)。

证据类型、等级与局限

  • 证据类型:前瞻性多中心随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于肺炎所致早期轻度ARDS(PaO2/FIO2 200–300)患者,早期无创通气虽改善PaO2/FIO2,但未减少插管需求,不能据此认为无创通气可替代标准氧疗来避免插管。
  • 48小时分钟通气量大于11 L/min可能预测无创通气失败(OR 1.176,95%CI 1.005–1.379,p=0.043),作者认为高分钟通气量可能预测无创通气失败。

指南或共识出处

  • 试验注册号NCT01581229,注册日期2012年4月19日。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: Our pilot study suggested that noninvasive ventilation (NIV) reduced the need for intubation compared with conventional administration of oxygen on patients with "early" stage of mild acute respiratory distress syndrome (ARDS, PaO2/FIO2 between 200 and 300).

OBJECTIVES: To evaluate whether early NIV can reduce the need for invasive ventilation in patients with pneumonia-induced early mild ARDS.

METHODS: Prospective, multicenter, randomized controlled trial (RCT) of NIV compared with conventional administration of oxygen through a Venturi mask. Primary outcome included the numbers of patients who met the intubation criteria.

RESULTS: Two hundred subjects were randomized to NIV (n = 102) or control (n = 98) groups from 21 centers. Baseline characteristics were similar in the two groups. In the NIV group, PaO2/FIO2 became significantly higher than in the control group at 2 h after randomization and remained stable for the first 72 h. NIV did not decrease the proportion of patients requiring intubation than in the control group (11/102 vs. 9/98, 10.8% vs. 9.2%, p = 0.706). The ICU mortality was similar in the two groups (7/102 vs. 7/98, 4.9% vs. 3.1%, p = 0.721). Multivariate analysis showed minute ventilation greater than 11 L/min at 48 h was the independent risk factor for NIV failure (OR, 1.176 [95% CI, 1.005-1.379], p = 0.043).

CONCLUSIONS: Treatment with NIV did not reduce the need for intubation among patients with pneumonia-induced early mild ARDS, despite the improved PaO2/FIO2 observed with NIV compared with standard oxygen therapy. High minute ventilation may predict NIV failure.

TRIAL REGISTRATION: NCT01581229 . Registered 19 April 2012.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. He H, Sun B, Liang L, et al. A multicenter RCT of noninvasive ventilation in pneumonia-induced early mild acute respiratory distress syndrome. Crit Care. 2019. PMID: 31484582. doi:10.1186/s13054-019-2575-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。